Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Bihua Chen reported a 22.60% stake in Bridgebio Oncology Therapeutics, Inc. (Schedule 13D/A)
Event Aug 11, 2025 · Filed Aug 13, 2025
Bihua Chen reported a 22.60% stake in Bridgebio Oncology Therapeutics, Inc., 17,878,594 shares, with active intent on Aug 11, 2025. Filed Aug 13, 2025 (Schedule 13D/A).
- Stake
- 22.60%
- Shares
- 17,878,594
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Helix Holdings II LLC | 5.70% | 4,528,186 |
| Cormorant Global Healthcare Master Fund, LP | 7.50% | 5,952,356 |
| Cormorant Global Healthcare GP, LLC | 7.50% | 5,952,356 |
| Bihua Chen | 22.60% | 17,878,594 |
Source
Related
- Bridgebio Oncology Therapeutics, Inc.
- Chen Bihua
- Bridgebio Oncology Therapeutics, Inc. shareholders
- Schedule 13D/A · Chen Bihua · Jul 6, 2026
- Form 4 · Beltran Pedro · Oct 5, 2026
- Form 4 · Ben Yong · Oct 5, 2026
- Form 4 · Elmelech Idan · Oct 5, 2026
- Form 4 · Cobo Marc · Oct 5, 2026
- Form 4 · Cobo Marc · Sep 14, 2026